Suchergebnisse - "Quesnel, Bruno"

PubPharm (253)

1

Small myeloid subclones are present at diagnosis of multiple myeloma in patients who develop secondary myelodysplastic syndromes

enthalten in: Haematologica | 2024

von Escure, G. | Fournier, E. | Saade, C. | +19

2

Genomic profiling of Mycosis Fungoides identifies patients at high risk of disease progression

enthalten in: Blood advances | 2024

von Fléchon, L. | Arib, I. | Dutta, A. | +32

3

MYC dependency in GLS1 and NAMPT is a therapeutic vulnerability in multiple myeloma

enthalten in: iScience | 2024

von Hasan Bou Issa, L. | Fléchon, L. | Laine, W. | +15

4

Tumor Necrosis Factor-Alpha/Tumor Necrosis Factor-Alpha Receptor 1 Signaling Pathway Leads to Thymocytes' Cell Death by Necroptosis in a Mouse Model of Acute Myeloid Leukemia

enthalten in: Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research | 2023

von Ben Khoud, M. | Jouy, N. | Driss, V. | +2

5

Successful bridging to cell therapy for relapsed/refractory acute lymphoblastic leukaemia with a combination of venetoclax and PEG-asparaginase

enthalten in: British journal of haematology | 2023

von Goursaud, L. | Berthon, C. | Quesnel, B.

6

IL-2 is inactivated by the acidic pH environment of tumors enabling engineering of a pH-selective mutein

enthalten in: Science immunology | 2022

von Gaggero, S. | Martinez-Fabregas, J. | Cozzani, A. | +18

7

A randomised phase II study of azacitidine (AZA) alone or with Lenalidomide (LEN), Valproic acid (VPA) or Idarubicin (IDA) in higher-Risk MDS or low blast AML : GFM's "pick a winner" trial, with the impact of somatic mutations

enthalten in: British journal of haematology | 2022

von Adès, L. | Duployez, N. | Guerci-Bresler, A. | +27

8

Resurgence of myeloproliferative neoplasm in patients in remission from blast transformation after treatment with hypomethylating agents

enthalten in: Leukemia research | 2022

von Chauvet, P. | Nibourel, O. | Berthon, C. | +5

9

Drug Repurposing to Enhance Antitumor Response to PD-1/PD-L1 Immune Checkpoint Inhibitors

enthalten in: Cancers | 2022

von Thuru, X. | Magnez, R. | El-Bouazzati, H. | +3

10

Single-agent 5-azacytidine as post-transplant maintenance in high-risk myeloid malignancies undergoing allogeneic hematopoietic cell transplantation

enthalten in: Annals of hematology | 2022

von Wattebled, K. | Drumez, E. | Coiteux, V. | +7

1
2
3
4
5
6
7
8
9
10
11
Nächster »
[26]